BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17168704)

  • 1. Cardioprotection with sildenafil: implications for clinical practice.
    Raja SG
    Curr Med Chem; 2006; 13(26):3155-64. PubMed ID: 17168704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5.
    Das S; Maulik N; Das DK; Kadowitz PJ; Bivalacqua TJ
    Drugs Exp Clin Res; 2002; 28(6):213-9. PubMed ID: 12776574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.
    Kukreja RC
    Br J Pharmacol; 2007 Mar; 150(5):538-40. PubMed ID: 17245364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy.
    Kukreja RC; Ockaili R; Salloum F; Yin C; Hawkins J; Das A; Xi L
    J Mol Cell Cardiol; 2004 Feb; 36(2):165-73. PubMed ID: 14871543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.
    Kukreja RC; Salloum F; Das A; Ockaili R; Yin C; Bremer YA; Fisher PW; Wittkamp M; Hawkins J; Chou E; Kukreja AK; Wang X; Marwaha VR; Xi L
    Vascul Pharmacol; 2005; 42(5-6):219-32. PubMed ID: 15922255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil in the treatment of erectile dysfunction.
    Schwartz I; McCarthy D
    N Engl J Med; 1998 Sep; 339(10):699-700; author reply 701-2. PubMed ID: 9729137
    [No Abstract]   [Full Text] [Related]  

  • 7. Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits.
    Bremer YA; Salloum F; Ockaili R; Chou E; Moskowitz WB; Kukreja RC
    Pediatr Res; 2005 Jan; 57(1):22-7. PubMed ID: 15531735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil and erectile dysfunction.
    Fabbri A; Aversa A; Isidori A
    J Endocrinol Invest; 1999 Jun; 22(6):486-92. PubMed ID: 10435861
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular data on sildenafil citrate: introduction.
    Zusman RM
    Am J Cardiol; 1999 Mar; 83(5A):1C-2C. PubMed ID: 10078536
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model.
    du Toit EF; Rossouw E; Salie R; Opie LH; Lochner A
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):23-31. PubMed ID: 15883753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil.
    Gibson A
    Eur J Pharmacol; 2001 Jan; 411(1-2):1-10. PubMed ID: 11137852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil and cardioprotection.
    Kukreja RC
    Curr Pharm Des; 2013; 19(39):6842-7. PubMed ID: 23590161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.
    Conti CR; Pepine CJ; Sweeney M
    Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should phosphodiesterase 5 selective inhibitors be used for uterine relaxation?
    Méhats C; Schmitz T; Breuiller-Fouché M; Leroy MJ; Cabrol D
    Am J Obstet Gynecol; 2006 Jul; 195(1):184-5. PubMed ID: 16813753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tough choices: the cost-effectiveness of sildenafil.
    McGarvey MR
    Ann Intern Med; 2000 Jun; 132(12):994-5. PubMed ID: 10858184
    [No Abstract]   [Full Text] [Related]  

  • 16. Viagra, sexual intercourse and acute myocardial infarction.
    Dakik HA; Al-Sayyed A; Sawaya JI
    Cardiology; 1999; 92(3):220. PubMed ID: 10754356
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction.
    Pérez NG; Piaggio MR; Ennis IL; Garciarena CD; Morales C; Escudero EM; Cingolani OH; Chiappe de Cingolani G; Yang XP; Cingolani HE
    Hypertension; 2007 May; 49(5):1095-103. PubMed ID: 17339532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-3-substituted imidazoquinazolinones: potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction.
    Rotella DP; Sun Z; Zhu Y; Krupinski J; Pongrac R; Seliger L; Normandin D; Macor JE
    J Med Chem; 2000 Apr; 43(7):1257-63. PubMed ID: 10753463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sildenafil].
    Wespes E; Sternon J; Hirsch E; Schulman C
    Rev Med Brux; 1998 Oct; 19(5 Pt 1):437-41. PubMed ID: 9844484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.
    Tsai BM; Turrentine MW; Sheridan BC; Wang M; Fiore AC; Brown JW; Meldrum DR
    Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.